Citryll BV

Quick facts

Phase 2 pipeline

• [89Zr]Zr-CIT
• CIT-013 high dose · Diabetes
  CIT-013 high dose is a small molecule that targets the SGLT2 receptor.
• CIT-013 low dose
• CIT-013 medium dose
  CIT-013 is a medium dose of a drug that targets a specific molecular pathway.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Citryll BV portfolio CI brief
• Citryll BV pipeline updates RSS